Cargando…

Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma

BACKGROUND: Hepatic inflammatory pseudotumor (IPT) is a rare benign lesion. Because there is no specific laboratory marker or radiographic appearance, the majority of reported cases of hepatic IPT have been diagnosed after surgery or at autopsy. The etiology of hepatic IPT remains unclear but severa...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Sho, Watanabe, Yusuke, Abe, Yuji, Shinkawa, Tomohiko, Tamiya, Sadafumi, Nishihara, Kazuyoshi, Nakano, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134473/
https://www.ncbi.nlm.nih.gov/pubmed/30203247
http://dx.doi.org/10.1186/s40792-018-0523-3
_version_ 1783354667009310720
author Endo, Sho
Watanabe, Yusuke
Abe, Yuji
Shinkawa, Tomohiko
Tamiya, Sadafumi
Nishihara, Kazuyoshi
Nakano, Toru
author_facet Endo, Sho
Watanabe, Yusuke
Abe, Yuji
Shinkawa, Tomohiko
Tamiya, Sadafumi
Nishihara, Kazuyoshi
Nakano, Toru
author_sort Endo, Sho
collection PubMed
description BACKGROUND: Hepatic inflammatory pseudotumor (IPT) is a rare benign lesion. Because there is no specific laboratory marker or radiographic appearance, the majority of reported cases of hepatic IPT have been diagnosed after surgery or at autopsy. The etiology of hepatic IPT remains unclear but several mechanisms have been postulated such as infection or immune reaction. CASE PRESENTATION: A 79-year-old woman had been seeing her family doctor for hypertension, and she had been diagnosed with liver dysfunction for about 10 years. She continued attending follow-ups because of her drinking habit. Two months before her visiting our institution, further elevation of hepatobiliary enzymes was noted, and abdominal ultrasonography showed a hepatic tumor 4 cm in diameter in the lateral segment, so she was referred to our hospital. Hepatocellular carcinoma (HCC) was suspected because alpha-fetoprotein (102 ng/ml) (AFP) and lectin 3 (L3) fraction (85.4%) were elevated and the appearance on enhanced computed tomography was not inconsistent with HCC. Thus, we performed laparoscopic hepatectomy. She recovered uneventfully and was discharged on postoperative day 7. Pathological diagnosis revealed that the tumor was hepatic IPT and that the background liver condition was primary biliary cholangitis (PBC). AFP and L3 fraction decreased to normal ranges after surgery. CONCLUSIONS: In 7 of 29 patients (24.1%) with reported cases of tumor markers in liver IPT, carbohydrate antigen 19-9 was elevated and AFP was elevated in 2 of 58 patients (3.4%). AFP is also frequently elevated in benign liver diseases such as hepatitis and liver cirrhosis, and L3 fraction has been used as a tumor marker for HCC with high specificity. To our knowledge, this is the first report of a case diagnosed with liver IPT in which AFP and L3 fraction increased before surgery and decreased to the normal range after resection. This confirms the rarity of hepatic IPT associated with PBC and elevated AFP and L3 fraction.
format Online
Article
Text
id pubmed-6134473
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-61344732018-09-27 Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma Endo, Sho Watanabe, Yusuke Abe, Yuji Shinkawa, Tomohiko Tamiya, Sadafumi Nishihara, Kazuyoshi Nakano, Toru Surg Case Rep Case Report BACKGROUND: Hepatic inflammatory pseudotumor (IPT) is a rare benign lesion. Because there is no specific laboratory marker or radiographic appearance, the majority of reported cases of hepatic IPT have been diagnosed after surgery or at autopsy. The etiology of hepatic IPT remains unclear but several mechanisms have been postulated such as infection or immune reaction. CASE PRESENTATION: A 79-year-old woman had been seeing her family doctor for hypertension, and she had been diagnosed with liver dysfunction for about 10 years. She continued attending follow-ups because of her drinking habit. Two months before her visiting our institution, further elevation of hepatobiliary enzymes was noted, and abdominal ultrasonography showed a hepatic tumor 4 cm in diameter in the lateral segment, so she was referred to our hospital. Hepatocellular carcinoma (HCC) was suspected because alpha-fetoprotein (102 ng/ml) (AFP) and lectin 3 (L3) fraction (85.4%) were elevated and the appearance on enhanced computed tomography was not inconsistent with HCC. Thus, we performed laparoscopic hepatectomy. She recovered uneventfully and was discharged on postoperative day 7. Pathological diagnosis revealed that the tumor was hepatic IPT and that the background liver condition was primary biliary cholangitis (PBC). AFP and L3 fraction decreased to normal ranges after surgery. CONCLUSIONS: In 7 of 29 patients (24.1%) with reported cases of tumor markers in liver IPT, carbohydrate antigen 19-9 was elevated and AFP was elevated in 2 of 58 patients (3.4%). AFP is also frequently elevated in benign liver diseases such as hepatitis and liver cirrhosis, and L3 fraction has been used as a tumor marker for HCC with high specificity. To our knowledge, this is the first report of a case diagnosed with liver IPT in which AFP and L3 fraction increased before surgery and decreased to the normal range after resection. This confirms the rarity of hepatic IPT associated with PBC and elevated AFP and L3 fraction. Springer Berlin Heidelberg 2018-09-10 /pmc/articles/PMC6134473/ /pubmed/30203247 http://dx.doi.org/10.1186/s40792-018-0523-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Case Report
Endo, Sho
Watanabe, Yusuke
Abe, Yuji
Shinkawa, Tomohiko
Tamiya, Sadafumi
Nishihara, Kazuyoshi
Nakano, Toru
Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma
title Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma
title_full Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma
title_fullStr Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma
title_full_unstemmed Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma
title_short Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma
title_sort hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134473/
https://www.ncbi.nlm.nih.gov/pubmed/30203247
http://dx.doi.org/10.1186/s40792-018-0523-3
work_keys_str_mv AT endosho hepaticinflammatorypseudotumorassociatedwithprimarybiliarycholangitisandelevatedalphafetoproteinlectin3fractionmimickinghepatocellularcarcinoma
AT watanabeyusuke hepaticinflammatorypseudotumorassociatedwithprimarybiliarycholangitisandelevatedalphafetoproteinlectin3fractionmimickinghepatocellularcarcinoma
AT abeyuji hepaticinflammatorypseudotumorassociatedwithprimarybiliarycholangitisandelevatedalphafetoproteinlectin3fractionmimickinghepatocellularcarcinoma
AT shinkawatomohiko hepaticinflammatorypseudotumorassociatedwithprimarybiliarycholangitisandelevatedalphafetoproteinlectin3fractionmimickinghepatocellularcarcinoma
AT tamiyasadafumi hepaticinflammatorypseudotumorassociatedwithprimarybiliarycholangitisandelevatedalphafetoproteinlectin3fractionmimickinghepatocellularcarcinoma
AT nishiharakazuyoshi hepaticinflammatorypseudotumorassociatedwithprimarybiliarycholangitisandelevatedalphafetoproteinlectin3fractionmimickinghepatocellularcarcinoma
AT nakanotoru hepaticinflammatorypseudotumorassociatedwithprimarybiliarycholangitisandelevatedalphafetoproteinlectin3fractionmimickinghepatocellularcarcinoma